Point72 Middle East FZE’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-46,032
Closed -$336K 52
2023
Q4
$336K Buy
+46,032
New +$363K 0.01% 931
2023
Q2
Sell
-7,280
Closed -$90.5K 1504
2023
Q1
$90.5K Sell
7,280
-5,908
-45% -$109K ﹤0.01% 1152
2022
Q4
$253K Buy
+13,188
New +$279K 0.01% 961

Other funds holding AHCO

Point72 Middle East FZE's AHCO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of AdaptHealth (AHCO) in Q1 2024, closing a stake of 46,032 shares — an estimated $336K sold.

Point72 Middle East FZE first reported a position in AHCO in Q4 2022 and held it in 3 quarters. The position peaked at $336K in Q4 2023. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining AdaptHealth position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 46,032 AdaptHealth shares in Q1 2024, an estimated $336K.
  • Point72 Middle East FZE first reported a position in AdaptHealth in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's AdaptHealth position peaked at $336K in Q4 2023.
  • 210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.